| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |